January 3, 2022
CTSW Represents Pharmaceutical Company Benuvia Holdings in M&A Transactions

CTSW represented Benuvia Holdings, LLC with the sale of Benuvia Manufacturing Inc., Benuvia Manufacturing, LLC, Benuvia Therapeutics LLC and Benuvia Therapeutics IP LLC. Benuvia Therapeutics markets Syndros, a U.S. FDA-approved cannabinoid drug and has a pipeline of clinical stage product candidates focused on rare diseases. The transactions are the latest in CTSW’s long history of […]

read more